Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Best Practices With CAR T-Cell Therapy Being Refined in Lymphomas

Sarah Karlovitch and Gina Columbus
Published: Wednesday, Jul 03, 2019

Alison R. Sehgal, MD

Alison R. Sehgal, MD

The addition of CAR T-cell therapy to the lymphoma armamentarium continues to lead to encouraging outcomes for relapsed/refractory patients. However, a host of other strategies have come to the forefront, including adverse event (AE) management, potential widespread administration, and further CAR T-cell products emerging in the pipeline.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication